Notice of Interim Results and Investor Presentation
News
Friday August 26, 2022
Notice of Interim Results and Investor Presentation
Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on the development of novel products to prevent life‐threatening infections, will announce its interim results for the period ended […]
Monday August 22, 2022
Notice of Interim Results and Investor Presentation
Destiny Pharma plc (“Destiny Pharma” or the “Company”) Notice of Interim Results and Investor Presentation Brighton, United Kingdom ‐ 22 August 2022 ‐ Destiny Pharma plc (AIM: DEST), a clinical […]